The Effect of Latanoprost 0.005% Solution in the Management of Scalp Alopecia Areata: A Randomized Double-Blind Placebo-Controlled Trial

    March 2022 in “ Dermatologic Therapy ”
    Mohammadreza Rafati, Reihaneh Alsadat Mahmoudian, Masoud Golpour, Armaghan Kazeminejad, Majid Saeedi, Zahra Nekoukar
    TLDR Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.
    This randomized double-blind placebo-controlled trial evaluated the effect of latanoprost 0.005% solution on scalp alopecia areata (AA) in 30 participants over 12 weeks. Participants received either latanoprost or a placebo, along with clobetasol 0.05% cream. The study found that latanoprost significantly increased hair density (37.2 ± 26.1 vs. 14.6 ± 18.6) and hair regrowth (58.3 ± 39.3 vs. 21.6 ± 24.1) compared to the control group, based on the Severity of Alopecia Tool (SALT) system (p = 0.03 and 0.02, respectively). However, there were no significant differences in the reduction of the hair loss area, overall SALT scores, or side effects between the two groups. The results suggest that latanoprost 0.005% solution is safe and effective for increasing hair density and regrowth in scalp AA.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 109 results

      community New Latanoprost-Based Formula Used by Hollywood Celebrities

      in Treatment  26 upvotes 1 year ago
      A new Latanoprost-based formula used by Hollywood celebrities to treat hair loss, with the formula containing minoxidil, tretinoin, melatonin, azelaic acid, zinc thymulin, vitamin B6, sandalore and methyl vanillate. It also mentions the potential of offering a combined sublingual minoxidil/oral dutasteride option in the future.

      community New Treatments, and a Huge Group Buy with Lots of Research

      in Research/Science  109 upvotes 1 year ago
      A user is organizing a group buy for various compounds aimed at reversing hair loss and gray hair, and improving brain health and fat loss. The user has developed a treatment plan based on extensive research and is inviting others to participate, with the option to choose only the compounds they need.

      community TH07 - A New Novel Topical Treatment for Androgenic Alopecia

      in Treatment  10 upvotes 5 months ago
      Triple Hair Inc. developed a new topical treatment, TH07, combining Finasteride, Latanoprost, and Minoxidil for androgenic alopecia. Users discussed its effectiveness compared to other treatments and shared their own product combinations.

    Related Research

    8 / 8 results